» Articles » PMID: 8995738

Age-related Glomerulosclerosis and Interstitial Fibrosis in Milan Normotensive Rats: a Podocyte Disease

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1997 Jan 1
PMID 8995738
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

In Milan normotensive (MNS) rats glomerulosclerosis and interstitial fibrosis develop spontaneously in the absence of hypertension. Renal changes were sequentially assessed in these rats between 2 and 10 months of age. At 10 months, rats were characterized by heavy proteinuria, increased serum creatinine, focal or global glomerulosclerosis in 51 +/- 12% of the glomeruli as well as tubulointerstitial injury involving > 25% of the section area. Cell injury in podocytes (evidenced as increased expression of desmin and by electron microscopy) and interstitial fibroblasts (increased expression of alpha-smooth muscle actin) and mild glomerular hypertrophy were witnessed as early as three to four months of age and preceded glomerulosclerosis and interstitial fibrosis. Only minor evidence of mesangial cell activation (as assessed by glomerular (de novo alpha-smooth muscle actin or type I collagen expression or increased cell proliferation) was noted throughout the observation period. Later stages of the disease were characterized by glomerular and/or tubulointerstitial macrophage influx and osteopontin expression (a chemoattractant), mild accumulation of lymphocytes, platelets, fibrinogen, as well as by a progressive accumulation of various matrix proteins. Progressive renal disease in MNS rats is thus noteworthy for the relative lack of mesangial cell activation. Rather, early podocyte damage, induced by yet unknown mechanisms, may underlie the development of glomerulosclerosis and subsequent interstitial fibrosis.

Citing Articles

Targeting cellular senescence in kidney diseases and aging: A focus on mesenchymal stem cells and their paracrine factors.

Hejazian S, Hejazian S, Mostafavi S, Hosseiniyan S, Montazersaheb S, Ardalan M Cell Commun Signal. 2024; 22(1):609.

PMID: 39696575 PMC: 11657437. DOI: 10.1186/s12964-024-01968-1.


Renal Expression and Localization of the Receptor for (Pro)renin and Its Ligands in Rodent Models of Diabetes, Metabolic Syndrome, and Age-Dependent Focal and Segmental Glomerulosclerosis.

Iacobini C, Vitale M, Sentinelli F, Haxhi J, Pugliese G, Menini S Int J Mol Sci. 2024; 25(4).

PMID: 38396894 PMC: 10888662. DOI: 10.3390/ijms25042217.


Interleukin-15 in kidney disease and therapeutics.

Hall G Curr Opin Nephrol Hypertens. 2024; 33(2):174-180.

PMID: 38164877 PMC: 10893218. DOI: 10.1097/MNH.0000000000000964.


Pan-Nox inhibitor treatment improves renal function in aging murine diabetic kidneys.

Park J, Yoon S, Ghee J, Yoo J, Cha J, Kang Y Kidney Res Clin Pract. 2023; 43(6):763-773.

PMID: 37559225 PMC: 11615449. DOI: 10.23876/j.krcp.23.004.


Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease.

Pippin J, Kaverina N, Wang Y, Eng D, Zeng Y, Tran U J Clin Invest. 2022; 132(16).

PMID: 35968783 PMC: 9374384. DOI: 10.1172/JCI156250.